Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CYP2A6 genetic variation and potential consequences.

Chun Xu1, Shari Goodz, Edward M Sellers

  • 1Centre for Addiction and Mental Health, University of Toronto, Toronto M5S 1A8, Canada.

Advanced Drug Delivery Reviews
|October 31, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Fentanyl-Responsive Microneedle Patch for Harm Reduction.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Role of oral microbiome in cancer immunotherapy.

Seminars in cancer biology·2026
Same author

Expert Consensus on Clinical Application for Digital Full-contour High-translucent/Ultra-translucent Zirconia Restorations.

The Chinese journal of dental research·2026
Same author

[Research Progress and Application Prospects of Saliva-Based Point-of-Care Testing Technologies].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
Same author

Schwann cell derived extracellular vesicles are multifunctional nanotherapeutic mediators for diabetic oral mucosal wound healing.

Discover nano·2026
Same author

Ca<sub>v</sub>3.2 T-type calcium channels in chronic pain: Structural insights, pharmacological advances and challenges in subtype selectivity.

British journal of pharmacology·2026

Genetic variations in human cytochrome P450 2A6 (CYP2A6) significantly impact its activity and expression. These genetic differences influence the metabolism of drugs and toxins, affecting health outcomes like smoking behaviors and lung cancer risk.

Area of Science:

  • Pharmacogenetics
  • Enzyme kinetics
  • Human genetics

Background:

  • Human cytochrome P450 2A6 (CYP2A6) exhibits substantial interindividual and interethnic variability in expression and activity.
  • This variability is primarily attributed to genetic polymorphisms within the CYP2A6 gene.

Purpose of the Study:

  • To review the current understanding of CYP2A6 genetic variants.
  • To summarize the impact of these variants on enzyme activity, substrate metabolism, and clinical consequences.

Main Methods:

  • Literature review of identified CYP2A6 genetic variants.
  • Analysis of studies investigating the functional consequences of these variants on enzyme activity.
  • Examination of population-based data on allele frequencies and their correlation with metabolic activity and health outcomes.

Related Experiment Videos

Main Results:

  • Thirteen genetic variants of CYP2A6, including alleles with inactive, decreased, or increased enzyme activity, have been identified.
  • CYP2A6 genetic variants influence the metabolism of key substrates such as nicotine, cotinine, tobacco-specific procarcinogens, and coumarin.
  • Significant ethnic variations in CYP2A6 allele frequencies contribute to interethnic differences in metabolic activity, smoking behaviors, and lung cancer risk.

Conclusions:

  • CYP2A6 genetic polymorphisms are a major determinant of interindividual and interethnic variability in drug and toxin metabolism.
  • Understanding CYP2A6 genetic variation is crucial for explaining differences in nicotine metabolism, smoking habits, and susceptibility to smoking-related diseases like lung cancer.
  • Further research into CYP2A6 genetics and its clinical implications is warranted.